File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-0027468889
- PMID: 8447474
- WOS: WOS:A1993KN68100048
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Plasmin potentiates induction of nitric oxide synthesis by interleukin- 1β in vascular smooth muscle cells
Title | Plasmin potentiates induction of nitric oxide synthesis by interleukin- 1β in vascular smooth muscle cells |
---|---|
Authors | |
Keywords | cytokine fibrinolysis tissue plasminogen activator |
Issue Date | 1993 |
Publisher | American Physiological Society. The Journal's web site is located at http://ajpcon.physiology.org/ |
Citation | American Journal Of Physiology - Heart And Circulatory Physiology, 1993, v. 264 n. 2 33-2, p. H617-H624 How to Cite? |
Abstract | Experiments were performed to examine the effect of the major fibrinolytic protease, plasmin, on the production of nitric oxide from interleukin-1β (IL-1β)-treated cultured human and rat aortic smooth muscle cells. Incubation of vascular smooth muscle cells with IL-1β resulted in significant accumulation of nitrite and nitrate in the culture media. Plasmin, either added exogenously or generated by the reaction of tissue plasminogen activator with plasminogen, potentiated the IL-1β-mediated release of nitrite and nitrate from smooth muscle cells in a concentration- dependent manner, without affecting the production of nitrite and nitrate from cells untreated with IL-1β. This potentiating effect was abolished when plasmin was incubated with the protease inhibitor, α2-antiplasmin. The perfusates from columns containing IL-1β-treated smooth muscle cells relaxed detector blood vessels without endothelium, and the addition of IL-1β- treated smooth muscle cells to suspensions of indomethacin-treated platelets inhibited their aggregation. Untreated smooth muscle cells or cells treated with plasmin alone did not have such effects. However, the simultaneous treatment of smooth muscle cells with IL-1β and plasmin markedly enhanced both the relaxing activities of the perfusates and the inhibition of platelet aggregation. Treatment of smooth muscle cells with N(G)-nitro-L-arginine inhibited the cytokine-mediated effects as well as the potentiating effect of plasmin. These results demonstrate that plasmin can enhance the production of nitric oxide by IL-1β-treated vascular smooth muscle cells. |
Persistent Identifier | http://hdl.handle.net/10722/171109 |
ISSN | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Durante, W | en_US |
dc.contributor.author | Schini, VB | en_US |
dc.contributor.author | Catovsky, S | en_US |
dc.contributor.author | Kroll, MH | en_US |
dc.contributor.author | Vanhoutte, PM | en_US |
dc.contributor.author | Schafer, AI | en_US |
dc.date.accessioned | 2012-10-30T06:12:13Z | - |
dc.date.available | 2012-10-30T06:12:13Z | - |
dc.date.issued | 1993 | en_US |
dc.identifier.citation | American Journal Of Physiology - Heart And Circulatory Physiology, 1993, v. 264 n. 2 33-2, p. H617-H624 | en_US |
dc.identifier.issn | 0002-9513 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/171109 | - |
dc.description.abstract | Experiments were performed to examine the effect of the major fibrinolytic protease, plasmin, on the production of nitric oxide from interleukin-1β (IL-1β)-treated cultured human and rat aortic smooth muscle cells. Incubation of vascular smooth muscle cells with IL-1β resulted in significant accumulation of nitrite and nitrate in the culture media. Plasmin, either added exogenously or generated by the reaction of tissue plasminogen activator with plasminogen, potentiated the IL-1β-mediated release of nitrite and nitrate from smooth muscle cells in a concentration- dependent manner, without affecting the production of nitrite and nitrate from cells untreated with IL-1β. This potentiating effect was abolished when plasmin was incubated with the protease inhibitor, α2-antiplasmin. The perfusates from columns containing IL-1β-treated smooth muscle cells relaxed detector blood vessels without endothelium, and the addition of IL-1β- treated smooth muscle cells to suspensions of indomethacin-treated platelets inhibited their aggregation. Untreated smooth muscle cells or cells treated with plasmin alone did not have such effects. However, the simultaneous treatment of smooth muscle cells with IL-1β and plasmin markedly enhanced both the relaxing activities of the perfusates and the inhibition of platelet aggregation. Treatment of smooth muscle cells with N(G)-nitro-L-arginine inhibited the cytokine-mediated effects as well as the potentiating effect of plasmin. These results demonstrate that plasmin can enhance the production of nitric oxide by IL-1β-treated vascular smooth muscle cells. | en_US |
dc.language | eng | en_US |
dc.publisher | American Physiological Society. The Journal's web site is located at http://ajpcon.physiology.org/ | en_US |
dc.relation.ispartof | American Journal of Physiology - Heart and Circulatory Physiology | en_US |
dc.subject | cytokine | - |
dc.subject | fibrinolysis | - |
dc.subject | tissue plasminogen activator | - |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Biological Assay | en_US |
dc.subject.mesh | Blood Platelets - Drug Effects | en_US |
dc.subject.mesh | Cells, Cultured | en_US |
dc.subject.mesh | Drug Synergism | en_US |
dc.subject.mesh | Fibrinolysin - Pharmacology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Interleukin-1 - Pharmacology | en_US |
dc.subject.mesh | Muscle, Smooth, Vascular - Cytology - Drug Effects - Metabolism | en_US |
dc.subject.mesh | Nitric Oxide - Metabolism | en_US |
dc.subject.mesh | Plasminogen - Pharmacology | en_US |
dc.subject.mesh | Platelet Aggregation - Drug Effects | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Thrombin - Pharmacology | en_US |
dc.subject.mesh | Tissue Plasminogen Activator - Pharmacology | en_US |
dc.subject.mesh | Vasodilation | en_US |
dc.title | Plasmin potentiates induction of nitric oxide synthesis by interleukin- 1β in vascular smooth muscle cells | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.pmid | 8447474 | - |
dc.identifier.scopus | eid_2-s2.0-0027468889 | en_US |
dc.identifier.volume | 264 | en_US |
dc.identifier.issue | 2 33-2 | en_US |
dc.identifier.spage | H617 | en_US |
dc.identifier.epage | H624 | en_US |
dc.identifier.isi | WOS:A1993KN68100048 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Durante, W=7006946922 | en_US |
dc.identifier.scopusauthorid | Schini, VB=7004113565 | en_US |
dc.identifier.scopusauthorid | Catovsky, S=6602617293 | en_US |
dc.identifier.scopusauthorid | Kroll, MH=7102187905 | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.scopusauthorid | Schafer, AI=7202243976 | en_US |
dc.identifier.issnl | 0002-9513 | - |